Copyright Reports & Markets. All rights reserved.

Global Biobank Management Systems Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Biobank Management Systems
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Biobank Management Systems by Type
    • 1.3.1 Overview: Global Biobank Management Systems Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Biobank Management Systems Consumption Value Market Share by Type in 2022
    • 1.3.3 Cloud
    • 1.3.4 On-Premises
  • 1.4 Global Biobank Management Systems Market by Application
    • 1.4.1 Overview: Global Biobank Management Systems Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Medical
    • 1.4.3 Pharmaceutical
    • 1.4.4 Laboratory
    • 1.4.5 CRO
    • 1.4.6 Others
  • 1.5 Global Biobank Management Systems Market Size & Forecast
  • 1.6 Global Biobank Management Systems Market Size and Forecast by Region
    • 1.6.1 Global Biobank Management Systems Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Biobank Management Systems Market Size by Region, (2018-2029)
    • 1.6.3 North America Biobank Management Systems Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Biobank Management Systems Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Biobank Management Systems Market Size and Prospect (2018-2029)
    • 1.6.6 South America Biobank Management Systems Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Biobank Management Systems Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Biobank Management Systems Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Agilent Technologies
    • 2.2.1 Agilent Technologies Details
    • 2.2.2 Agilent Technologies Major Business
    • 2.2.3 Agilent Technologies Biobank Management Systems Product and Solutions
    • 2.2.4 Agilent Technologies Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Agilent Technologies Recent Developments and Future Plans
  • 2.3 Autoscribe Informatics
    • 2.3.1 Autoscribe Informatics Details
    • 2.3.2 Autoscribe Informatics Major Business
    • 2.3.3 Autoscribe Informatics Biobank Management Systems Product and Solutions
    • 2.3.4 Autoscribe Informatics Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Autoscribe Informatics Recent Developments and Future Plans
  • 2.4 DiData
    • 2.4.1 DiData Details
    • 2.4.2 DiData Major Business
    • 2.4.3 DiData Biobank Management Systems Product and Solutions
    • 2.4.4 DiData Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 DiData Recent Developments and Future Plans
  • 2.5 AgileBio
    • 2.5.1 AgileBio Details
    • 2.5.2 AgileBio Major Business
    • 2.5.3 AgileBio Biobank Management Systems Product and Solutions
    • 2.5.4 AgileBio Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 AgileBio Recent Developments and Future Plans
  • 2.6 CloudLIMS
    • 2.6.1 CloudLIMS Details
    • 2.6.2 CloudLIMS Major Business
    • 2.6.3 CloudLIMS Biobank Management Systems Product and Solutions
    • 2.6.4 CloudLIMS Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 CloudLIMS Recent Developments and Future Plans
  • 2.7 Modul-Bio
    • 2.7.1 Modul-Bio Details
    • 2.7.2 Modul-Bio Major Business
    • 2.7.3 Modul-Bio Biobank Management Systems Product and Solutions
    • 2.7.4 Modul-Bio Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Modul-Bio Recent Developments and Future Plans
  • 2.8 TD Biobank
    • 2.8.1 TD Biobank Details
    • 2.8.2 TD Biobank Major Business
    • 2.8.3 TD Biobank Biobank Management Systems Product and Solutions
    • 2.8.4 TD Biobank Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 TD Biobank Recent Developments and Future Plans
  • 2.9 OpenSpecimen
    • 2.9.1 OpenSpecimen Details
    • 2.9.2 OpenSpecimen Major Business
    • 2.9.3 OpenSpecimen Biobank Management Systems Product and Solutions
    • 2.9.4 OpenSpecimen Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 OpenSpecimen Recent Developments and Future Plans
  • 2.10 Information Management Services
    • 2.10.1 Information Management Services Details
    • 2.10.2 Information Management Services Major Business
    • 2.10.3 Information Management Services Biobank Management Systems Product and Solutions
    • 2.10.4 Information Management Services Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Information Management Services Recent Developments and Future Plans
  • 2.11 Azenta
    • 2.11.1 Azenta Details
    • 2.11.2 Azenta Major Business
    • 2.11.3 Azenta Biobank Management Systems Product and Solutions
    • 2.11.4 Azenta Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Azenta Recent Developments and Future Plans
  • 2.12 BBMS
    • 2.12.1 BBMS Details
    • 2.12.2 BBMS Major Business
    • 2.12.3 BBMS Biobank Management Systems Product and Solutions
    • 2.12.4 BBMS Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 BBMS Recent Developments and Future Plans
  • 2.13 LabKey
    • 2.13.1 LabKey Details
    • 2.13.2 LabKey Major Business
    • 2.13.3 LabKey Biobank Management Systems Product and Solutions
    • 2.13.4 LabKey Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 LabKey Recent Developments and Future Plans
  • 2.14 FreeLIMS
    • 2.14.1 FreeLIMS Details
    • 2.14.2 FreeLIMS Major Business
    • 2.14.3 FreeLIMS Biobank Management Systems Product and Solutions
    • 2.14.4 FreeLIMS Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 FreeLIMS Recent Developments and Future Plans
  • 2.15 LabWare
    • 2.15.1 LabWare Details
    • 2.15.2 LabWare Major Business
    • 2.15.3 LabWare Biobank Management Systems Product and Solutions
    • 2.15.4 LabWare Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 LabWare Recent Developments and Future Plans
  • 2.16 Titian
    • 2.16.1 Titian Details
    • 2.16.2 Titian Major Business
    • 2.16.3 Titian Biobank Management Systems Product and Solutions
    • 2.16.4 Titian Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Titian Recent Developments and Future Plans
  • 2.17 Octalsoft
    • 2.17.1 Octalsoft Details
    • 2.17.2 Octalsoft Major Business
    • 2.17.3 Octalsoft Biobank Management Systems Product and Solutions
    • 2.17.4 Octalsoft Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Octalsoft Recent Developments and Future Plans
  • 2.18 Interactive Software
    • 2.18.1 Interactive Software Details
    • 2.18.2 Interactive Software Major Business
    • 2.18.3 Interactive Software Biobank Management Systems Product and Solutions
    • 2.18.4 Interactive Software Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Interactive Software Recent Developments and Future Plans
  • 2.19 eLabNext
    • 2.19.1 eLabNext Details
    • 2.19.2 eLabNext Major Business
    • 2.19.3 eLabNext Biobank Management Systems Product and Solutions
    • 2.19.4 eLabNext Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 eLabNext Recent Developments and Future Plans
  • 2.20 SoftSystem
    • 2.20.1 SoftSystem Details
    • 2.20.2 SoftSystem Major Business
    • 2.20.3 SoftSystem Biobank Management Systems Product and Solutions
    • 2.20.4 SoftSystem Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 SoftSystem Recent Developments and Future Plans
  • 2.21 STARLIMS
    • 2.21.1 STARLIMS Details
    • 2.21.2 STARLIMS Major Business
    • 2.21.3 STARLIMS Biobank Management Systems Product and Solutions
    • 2.21.4 STARLIMS Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 STARLIMS Recent Developments and Future Plans
  • 2.22 NEST
    • 2.22.1 NEST Details
    • 2.22.2 NEST Major Business
    • 2.22.3 NEST Biobank Management Systems Product and Solutions
    • 2.22.4 NEST Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.22.5 NEST Recent Developments and Future Plans
  • 2.23 Origincell
    • 2.23.1 Origincell Details
    • 2.23.2 Origincell Major Business
    • 2.23.3 Origincell Biobank Management Systems Product and Solutions
    • 2.23.4 Origincell Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.23.5 Origincell Recent Developments and Future Plans
  • 2.24 Improve Medical
    • 2.24.1 Improve Medical Details
    • 2.24.2 Improve Medical Major Business
    • 2.24.3 Improve Medical Biobank Management Systems Product and Solutions
    • 2.24.4 Improve Medical Biobank Management Systems Revenue, Gross Margin and Market Share (2018-2023)
    • 2.24.5 Improve Medical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Biobank Management Systems Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Biobank Management Systems by Company Revenue
    • 3.2.2 Top 3 Biobank Management Systems Players Market Share in 2022
    • 3.2.3 Top 6 Biobank Management Systems Players Market Share in 2022
  • 3.3 Biobank Management Systems Market: Overall Company Footprint Analysis
    • 3.3.1 Biobank Management Systems Market: Region Footprint
    • 3.3.2 Biobank Management Systems Market: Company Product Type Footprint
    • 3.3.3 Biobank Management Systems Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Biobank Management Systems Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Biobank Management Systems Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Biobank Management Systems Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Biobank Management Systems Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Biobank Management Systems Consumption Value by Type (2018-2029)
  • 6.2 North America Biobank Management Systems Consumption Value by Application (2018-2029)
  • 6.3 North America Biobank Management Systems Market Size by Country
    • 6.3.1 North America Biobank Management Systems Consumption Value by Country (2018-2029)
    • 6.3.2 United States Biobank Management Systems Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Biobank Management Systems Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Biobank Management Systems Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Biobank Management Systems Consumption Value by Type (2018-2029)
  • 7.2 Europe Biobank Management Systems Consumption Value by Application (2018-2029)
  • 7.3 Europe Biobank Management Systems Market Size by Country
    • 7.3.1 Europe Biobank Management Systems Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Biobank Management Systems Market Size and Forecast (2018-2029)
    • 7.3.3 France Biobank Management Systems Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Biobank Management Systems Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Biobank Management Systems Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Biobank Management Systems Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Biobank Management Systems Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Biobank Management Systems Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Biobank Management Systems Market Size by Region
    • 8.3.1 Asia-Pacific Biobank Management Systems Consumption Value by Region (2018-2029)
    • 8.3.2 China Biobank Management Systems Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Biobank Management Systems Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Biobank Management Systems Market Size and Forecast (2018-2029)
    • 8.3.5 India Biobank Management Systems Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Biobank Management Systems Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Biobank Management Systems Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Biobank Management Systems Consumption Value by Type (2018-2029)
  • 9.2 South America Biobank Management Systems Consumption Value by Application (2018-2029)
  • 9.3 South America Biobank Management Systems Market Size by Country
    • 9.3.1 South America Biobank Management Systems Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Biobank Management Systems Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Biobank Management Systems Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Biobank Management Systems Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Biobank Management Systems Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Biobank Management Systems Market Size by Country
    • 10.3.1 Middle East & Africa Biobank Management Systems Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Biobank Management Systems Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Biobank Management Systems Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Biobank Management Systems Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Biobank Management Systems Market Drivers
  • 11.2 Biobank Management Systems Market Restraints
  • 11.3 Biobank Management Systems Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Biobank Management Systems Industry Chain
  • 12.2 Biobank Management Systems Upstream Analysis
  • 12.3 Biobank Management Systems Midstream Analysis
  • 12.4 Biobank Management Systems Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Biobank Management Systems market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    Biobank Management System is a sample library resource management system based on cell sample workflow. According to the operations involved in the laboratory sample workflow, the entire process recording of the sample life cycle and efficient and continuous management of all-round quality control are achieved.
    Biobanks are becoming increasingly important to many organizations in the biotechnology, pharmaceutical industries, and medical research fields as there is a growing awareness of their ability to answer relevant research questions. The higher the quality of biobanks, the more accurate or fine-grained the research based on them will be. This requires excellent management of various samples such as blood, tissue, saliva, DNA, etc., integration with electronic medical/health records (EMR/EHR), and compliance with relevant regulatory environments such as HTA, GCLP, MHRA, FDA 21 CFR Part 11 and other similar requirements. Real-time complete sample inventory is critical, including tracking aliquots, pooled samples, and samples processed for experiments and subsequently stored. Other requirements often include logistics management and cold chain monitoring.
    The Global Info Research report includes an overview of the development of the Biobank Management Systems industry chain, the market status of Medical (Cloud, On-Premises), Pharmaceutical (Cloud, On-Premises), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biobank Management Systems.
    Regionally, the report analyzes the Biobank Management Systems markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biobank Management Systems market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Biobank Management Systems market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biobank Management Systems industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cloud, On-Premises).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biobank Management Systems market.
    Regional Analysis: The report involves examining the Biobank Management Systems market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biobank Management Systems market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Biobank Management Systems:
    Company Analysis: Report covers individual Biobank Management Systems players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biobank Management Systems This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medical, Pharmaceutical).
    Technology Analysis: Report covers specific technologies relevant to Biobank Management Systems. It assesses the current state, advancements, and potential future developments in Biobank Management Systems areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biobank Management Systems market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Biobank Management Systems market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Cloud
    On-Premises
    Market segment by Application
    Medical
    Pharmaceutical
    Laboratory
    CRO
    Others
    Market segment by players, this report covers
    Thermo Fisher Scientific
    Agilent Technologies
    Autoscribe Informatics
    DiData
    AgileBio
    CloudLIMS
    Modul-Bio
    TD Biobank
    OpenSpecimen
    Information Management Services
    Azenta
    BBMS
    LabKey
    FreeLIMS
    LabWare
    Titian
    Octalsoft
    Interactive Software
    eLabNext
    SoftSystem
    STARLIMS
    NEST
    Origincell
    Improve Medical
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Biobank Management Systems product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Biobank Management Systems, with revenue, gross margin and global market share of Biobank Management Systems from 2018 to 2023.
    Chapter 3, the Biobank Management Systems competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biobank Management Systems market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Biobank Management Systems.
    Chapter 13, to describe Biobank Management Systems research findings and conclusion.

    Buy now